➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Johnson and Johnson
Colorcon
Merck
AstraZeneca

Last Updated: September 16, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AZATHIOPRINE

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Azathioprine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000524 ↗ Myocarditis Treatment Trial Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 2 1986-07-01 To determine whether immunosuppressive treatment improved cardiac function in patients with biopsy-proven myocarditis.
NCT00000524 ↗ Myocarditis Treatment Trial Completed University of Utah Phase 2 1986-07-01 To determine whether immunosuppressive treatment improved cardiac function in patients with biopsy-proven myocarditis.
NCT00000936 ↗ A Study To Test An Anti-Rejection Therapy After Kidney Transplantation Terminated National Institute of Allergy and Infectious Diseases (NIAID) Phase 3 1999-11-01 Kidney transplantation is often successful. However, despite aggressive anti-rejection drug therapy, some patients will reject their new kidney. This study is designed to test two anti-rejection approaches. Two medications in this study are currently used in children, but there is no information regarding which drug is safer or more effective. Survival rates in renal transplantation are unacceptably low. Therefore, there is a need for an improved post-transplant treatment, such as the induction therapy used in this study.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Azathioprine

Condition Name

Condition Name for Azathioprine
Intervention Trials
Crohn's Disease 27
Ulcerative Colitis 19
Lupus Nephritis 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Azathioprine
Intervention Trials
Crohn Disease 40
Colitis 24
Colitis, Ulcerative 24
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Azathioprine

Trials by Country

Trials by Country for Azathioprine
Location Trials
United States 420
Canada 48
France 39
China 33
Italy 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Azathioprine
Location Trials
California 30
New York 25
North Carolina 22
Pennsylvania 22
Illinois 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Azathioprine

Clinical Trial Phase

Clinical Trial Phase for Azathioprine
Clinical Trial Phase Trials
Phase 4 66
Phase 3 71
Phase 2/Phase 3 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Azathioprine
Clinical Trial Phase Trials
Completed 106
Recruiting 59
Not yet recruiting 42
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Azathioprine

Sponsor Name

Sponsor Name for Azathioprine
Sponsor Trials
Assistance Publique - Hôpitaux de Paris 18
National Institute of Allergy and Infectious Diseases (NIAID) 11
Hoffmann-La Roche 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Azathioprine
Sponsor Trials
Other 364
Industry 110
NIH 32
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
AstraZeneca
McKesson
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.